HU188585B - Process for producing new benztriazole derivatives - Google Patents

Process for producing new benztriazole derivatives Download PDF

Info

Publication number
HU188585B
HU188585B HU822374A HU237482A HU188585B HU 188585 B HU188585 B HU 188585B HU 822374 A HU822374 A HU 822374A HU 237482 A HU237482 A HU 237482A HU 188585 B HU188585 B HU 188585B
Authority
HU
Hungary
Prior art keywords
methyl
dihydro
formula
pyridazinone
phenyl
Prior art date
Application number
HU822374A
Other languages
English (en)
Hungarian (hu)
Inventor
Norbert Hauel
Volkhard Austel
Joachim Heider
Willi Reiffen
Walter Haarmann
Willi Diederen
Original Assignee
Dr Karl Thomae Gmbh,De
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dr Karl Thomae Gmbh,De filed Critical Dr Karl Thomae Gmbh,De
Publication of HU188585B publication Critical patent/HU188585B/hu

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D237/00Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/02Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
    • C07D237/04Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having less than three double bonds between ring members or between ring members and non-ring members
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/16Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms condensed with carbocyclic rings or ring systems
    • C07D249/18Benzotriazoles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
HU822374A 1981-07-25 1982-07-22 Process for producing new benztriazole derivatives HU188585B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19813129447 DE3129447A1 (de) 1981-07-25 1981-07-25 "neue benztriazole, ihre herstellung und ihre verwendung als arzneimittel"

Publications (1)

Publication Number Publication Date
HU188585B true HU188585B (en) 1986-04-28

Family

ID=6137768

Family Applications (1)

Application Number Title Priority Date Filing Date
HU822374A HU188585B (en) 1981-07-25 1982-07-22 Process for producing new benztriazole derivatives

Country Status (27)

Country Link
US (1) US4616018A (fr)
EP (1) EP0071102B1 (fr)
JP (1) JPS5824582A (fr)
KR (1) KR880001476B1 (fr)
AR (1) AR230631A1 (fr)
AT (1) ATE16184T1 (fr)
AU (1) AU554184B2 (fr)
CA (1) CA1189076A (fr)
CS (1) CS226747B2 (fr)
DD (1) DD202564A5 (fr)
DE (2) DE3129447A1 (fr)
DK (1) DK331282A (fr)
ES (2) ES514274A0 (fr)
FI (1) FI73994C (fr)
GB (1) GB2107703B (fr)
GR (1) GR76230B (fr)
HU (1) HU188585B (fr)
IE (1) IE53664B1 (fr)
IL (1) IL66385A (fr)
NO (1) NO159273C (fr)
NZ (1) NZ201364A (fr)
PH (1) PH19512A (fr)
PL (1) PL130643B1 (fr)
PT (1) PT75313B (fr)
SU (1) SU1179927A3 (fr)
YU (1) YU42783B (fr)
ZA (1) ZA825275B (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8320005D0 (en) * 1983-07-25 1983-08-24 Fujisawa Pharmaceutical Co Benzothiazoline derivatives
DE3511110A1 (de) * 1985-03-27 1986-10-02 Dr. Karl Thomae Gmbh, 7950 Biberach Neue pyridazinone, ihre herstellung und diese verbindungen enthaltende arzneimittel
DE3734083A1 (de) * 1987-10-08 1989-04-20 Heumann Pharma Gmbh & Co Benzimidazole, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
DE68924308T2 (de) * 1988-07-11 1996-04-04 Akzo Nobel Nv Pyridazinon-Derivate.
DE3934436A1 (de) * 1989-06-01 1991-04-18 Thomae Gmbh Dr K 2-hydroxy-n-propylamine, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung
WO2003001968A2 (fr) * 2001-06-26 2003-01-09 Beth Israel Deaconess Medical Center Compositions et procedes prohibant l'activation plaquettaire et la thrombose
GB201321740D0 (en) * 2013-12-09 2014-01-22 Ucb Pharma Sa Therapeutic agents

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2516040C2 (de) * 1974-06-10 1984-12-20 Dr. Karl Thomae Gmbh, 7950 Biberach Benzimidazole, Verfahren zu deren Herstellung und diese enthaltende Arzneimittel
ES8101067A1 (es) * 1978-08-25 1980-12-01 Thomae Gmbh Dr K Procedimiento para la preparacion de nuevos bencimidazoles sustituidos en posicion 5 o 6 con un anillo de piridazinona
DE2845220A1 (de) * 1978-10-17 1980-04-30 Yoshitomi Pharmaceutical Pyridazinon-derivate, ihre salze mit saeuren, verfahren zu ihrer herstellung und ihre verwendung bei der behandlung von thrombosen und hypertonie
US4258185A (en) * 1978-10-17 1981-03-24 Yoshitomi Pharmaceutical Industries, Ltd. Pyridazinone compounds

Also Published As

Publication number Publication date
EP0071102B1 (fr) 1985-10-23
DD202564A5 (de) 1983-09-21
AU554184B2 (en) 1986-08-14
FI822549L (fi) 1983-01-26
FI822549A0 (fi) 1982-07-20
GB2107703A (en) 1983-05-05
KR880001476B1 (ko) 1988-08-13
IL66385A (en) 1985-11-29
YU159782A (en) 1984-08-31
GR76230B (fr) 1984-08-04
PT75313B (de) 1985-11-29
NZ201364A (en) 1986-01-24
ES8400744A1 (es) 1983-11-01
IL66385A0 (en) 1982-11-30
AR230631A1 (es) 1984-05-31
SU1179927A3 (ru) 1985-09-15
PL130643B1 (en) 1984-08-31
DK331282A (da) 1983-01-26
YU42783B (en) 1988-12-31
US4616018A (en) 1986-10-07
ATE16184T1 (de) 1985-11-15
DE3267020D1 (en) 1985-11-28
EP0071102A1 (fr) 1983-02-09
JPS5824582A (ja) 1983-02-14
ES8308325A1 (es) 1983-08-16
PL237601A1 (en) 1983-05-09
NO822119L (no) 1983-01-26
PH19512A (en) 1986-05-14
NO159273C (no) 1988-12-14
DE3129447A1 (de) 1983-02-10
PT75313A (de) 1982-08-01
GB2107703B (en) 1985-06-12
IE53664B1 (en) 1989-01-04
NO159273B (no) 1988-09-05
CA1189076A (fr) 1985-06-18
IE821781L (en) 1983-01-25
ES514274A0 (es) 1983-08-16
FI73994C (fi) 1987-12-10
FI73994B (fi) 1987-08-31
AU8637782A (en) 1983-02-03
KR840000530A (ko) 1984-02-25
ES519351A0 (es) 1983-11-01
ZA825275B (en) 1984-03-28
CS226747B2 (en) 1984-04-16

Similar Documents

Publication Publication Date Title
FI66372B (fi) Foerfarande foer framstaellning av farmakologiskt verkande i 5- eller 6-staellning med en pyridazinonring substituerade besimidazoler
Thyes et al. 6-Aryl-4, 5-dihydro-3 (2H)-pyridazinones. A new class of compounds with platelet aggregation inhibiting and hypotensive activities
US4075340A (en) Thieno [2,3-C] pyridine derivatives and therapeutic composition containing same
US4026891A (en) 5- Or 6-pyridazinyl-benzimidazoles and salts thereof
NO152048B (no) Analogifremgangsmaate ved fremstilling av nye, terapeutisk aktive 5h-2,3-benzodiazepinderivater
EP0198456B1 (fr) Dérivés de la 1,7-naphtyridine et préparations médicales les contenant
DE3511110A1 (de) Neue pyridazinone, ihre herstellung und diese verbindungen enthaltende arzneimittel
US4260621A (en) 3-Amino-4-phenyl-6-piperidino-1H-pyrazolo[3,4-b]-pyridines and salts thereof
US4992442A (en) Pyrrolo(3,2-e)pyrazolo(1,5-a)pyrimidine derivative and medicine comprising the same
HU188585B (en) Process for producing new benztriazole derivatives
SU1503681A3 (ru) Способ получени производных 1-(гидроксистирил)-5Н-2,3-бензодиазепина
US3824271A (en) 3-alkyl-3-(benzoyl)propionitriles
DE2427943A1 (de) Neue benzimidazole
JPS6041076B2 (ja) 5,6,7,7a−テトラヒドロ−4H−チエノ(3,2−c)ピリジン−2−オン誘導体、その製法および血小板凝集抑制剤
GB2057427A (en) Oxoimidazolinealkanoic acids and their salts and esters their preparation and pharmaceutical compositions containing them
DE10064997A1 (de) Benzoylpyridazine
US4544562A (en) 6-Aryl-4,5-dihydro-3(2H)-pyridazinones, and their use as anti-hypertensive and anti-thrombocyte agents
US4629789A (en) Alkyl substituted pyridazinones and pharmaceutical compositions
US4399137A (en) 6-Imidazol-1-yl-3-hydrazino-pyridazines, their preparation and antihypertensive use
US4699909A (en) Benzotriazolyl-4,5-dihydro-3(2H)-pyridazinones
JPH0662608B2 (ja) カルボスチリル誘導体
EP0658555B1 (fr) Dérivés de la pyridazinone, procédés de production et utilisation
JPS6197284A (ja) ピリジルフエニルピリダジノン変力剤
JPH05331149A (ja) フェノール誘導体
JPS62258378A (ja) チアジアジン−2(3h)−オン誘導体